Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Phathom Pharmaceuticals (NASDAQ:PHAT) through any online brokerage.
Other companies in Phathom Pharmaceuticals’s space includes: Theravance Biopharma Inc (NASDAQ:TBPH), GH Research PLC (NASDAQ:GHRS), Bioage Labs Inc (NASDAQ:BIOA), WAVE Life Sciences Ltd (NASDAQ:WVE) and Xeris Biopharma Holdings Inc (NASDAQ:XERS).
Phathom Pharmaceuticals has a consensus price target of $20.43.
The stock price for Phathom Pharmaceuticals (NASDAQ: PHAT) is $12.9489 last updated April 21, 2026 at 7:16 PM EDT.
There are no upcoming dividends for Phathom Pharmaceuticals.
Phathom Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Phathom Pharmaceuticals.
Phathom Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.